show episodes
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
  continue reading
 
Loading …
show series
 
In this episode, we explore how artificial intelligence (AI) is transforming the pharmaceutical industry with Ilyssa Levins, founder and CEO of SecureChek.ai. Ilyssa shares how her company is automating and streamlining the creation and compliance of pharma marketing materials, cutting approval times from months to days while ensuring error-free su…
  continue reading
 
In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and opportunities it presents. They discuss the shift from traditional drug development methods to innovative approaches driven by …
  continue reading
 
In this episode, we explore how artificial intelligence is revolutionising health equity. Dr Rav Seeruthun, co-founder and CEO of HealthEquity.AI, shares his journey from practising medicine to leading a pioneering AI-driven healthcare initiative. We discuss the biggest misconceptions about health equity, how AI can uncover hidden disparities in he…
  continue reading
 
In this episode, we explore how artificial intelligence (AI) reflects and often amplifies gender bias from the real world. Sandra Struebing, head of the Global Women Employee Network and a data and AI specialist, joins us to discuss the roots of gender bias in AI and how to address it effectively. Sandra shares her insights on how data drives AI mo…
  continue reading
 
In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care. He explains the targeted nature of these therapies, the importance of personalized medicine, and the challenges faced in regulatory processes and patient safety. The discussion al…
  continue reading
 
In this episode of AI for Pharma Growth, Dr. Andree Bates explores the critical issue of cybersecurity in healthcare with Terry Ziemniak, a cybersecurity leader with over 20 years of experience. Terry shares insights into why healthcare is one of the most targeted industries for cyberattacks and what organisations can do to protect sensitive data w…
  continue reading
 
In this episode of AI for Pharma Growth, Dr. Andree Bates hosts Dr. Louis Rosenberg, founder and CEO of Unanimous AI, to discuss the revolutionary impact of swarm intelligence on group decision-making and forecasting in the pharmaceutical industry and beyond. Dr. Rosenberg explains how Unanimous AI's platforms—Swarm and ThinkScape—enhance the colle…
  continue reading
 
In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA. He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness …
  continue reading
 
In this episode, we explore the intersection of artificial intelligence (AI) and healthcare supply chains with Philip Ashton, founder and CEO of 7bridges. As healthcare systems globalise, the pharmaceutical supply chain becomes increasingly complex and vulnerable to disruptions. Ashton reveals how AI and real-world data are revolutionising supply c…
  continue reading
 
In this episode, Dr Andree Bates sits down with Dr Jayne Morgan, Vice President of Medical Affairs and On-Air Medical Expert. They discuss the transformative role of artificial intelligence (AI) in patient care, telehealth, and the future of diagnostics. Dr Morgan provides an insider’s perspective on the challenges and ethical concerns facing AI-dr…
  continue reading
 
In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes…
  continue reading
 
In this episode, we dive into the future of cancer treatment with Dr. Sola Adeleke, founder and CEO of Curenetics. Dr. Adeleke shares how his company is using artificial intelligence (AI) to predict cancer treatment outcomes and improve the personalisation of cancer therapies, particularly in immunotherapy. We explore the key challenges of current …
  continue reading
 
In this episode, Dr. Andree Bates speaks with Dr. Jordan Lane, Chief Scientific Officer of Ignota Labs, about how explainable AI is transforming the pharmaceutical industry. They explore how Ignota Labs leverages AI to rescue drug projects that previously failed due to safety concerns. Dr. Lane highlights the groundbreaking technology behind the Sa…
  continue reading
 
In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Philip Vyt, a renowned expert in omnichannel strategy and founder of Shyft, a consultancy specializing in omnichannel approaches for biopharma. They delve into the key concepts behind omnichannel and its distinction from multichannel, emphasizing the centrality of healthcare professionals (H…
  continue reading
 
In this episode of "AI for Pharma Growth" Dr Andree Bates sits down with Ken Pomella, CEO of RevStar, to delve into the intricate balance between innovation and ethical responsibility in the development of AI technologies. They explore the ethical challenges that AI poses, particularly in the pharmaceutical and healthcare sectors, and discuss ways …
  continue reading
 
In this episode of AI for Pharma Growth, Dr. Andree Bates sits down with Cav. Franco Lofranco, CEO of APM Global, to explore how artificial intelligence is revolutionising the healthcare industry, making it more affordable and accessible. They discuss the challenges of the current healthcare system in the United States, including high costs and ine…
  continue reading
 
In this episode, Dr. Na-Ri and Ian Wendt welcome back Kristiaan Rawlings, from EPM Scientific to discuss the latest trends in pharma and biotech hiring. They explore the key drivers of hiring, the impact of AI and advanced analytics, and the evolving expectations of candidates. Kristiaan emphasizes the importance of change agents in the industry an…
  continue reading
 
In this episode, host Dr. Andree Bates sits down with Raj Bhattacharya, who previously headed the go-to-market function for pharma and life sciences at One Network. Raj shares his extensive background in the pharmaceutical industry, having worked in production, formulations R&D, and supply chain roles for companies like AstraZeneca and Allergan. Ra…
  continue reading
 
This episode of AI for Pharma Growth features an interview with Noah Kjos, the Co-Founder and COO of DeepTrust, a company that offers an AI tool to authenticate whether an audio recording was generated by an AI voice or a human voice. Andree and Noah discuss the growing threat of deep fake audio scams and the importance of being able to verify the …
  continue reading
 
In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis. They discuss the evolution of US policy on opioids, the impact of the crisis on different communities, the role of legislation and harm reduction, the accountability of the pharmaceutical industry, barriers to a…
  continue reading
 
This episode of AI for Pharma Growth features an interview with Torrey Smith, the Co-Founder and CEO of Endiatx, a company developing a revolutionary robotic pill that can provide a non-invasive way to observe inside the human body. Torrey explains the journey of Endiatx, progressing from a startup in a Silicon Valley garage to clinical trials and …
  continue reading
 
This episode features an interview with Marco Baldocchi, the founder and CEO of the Marco Baldocchi Group, who specialises in leveraging AI in neuromarketing. Marco discusses his background in marketing and economics, and how a personal experience with buying a car led him to explore the unconscious decision-making processes of consumers. Marco exp…
  continue reading
 
Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare. He highlights the importance of medical affairs in conveying the science of pharmaceutical companies and translating complex data into a meaningful narrative for healthcare providers, payers, patients, and policymakers. M…
  continue reading
 
In this episode, Dr. Andree Bates speaks to Mariana Matus, the co-founder and CEO of Biobot, a company that is transforming wastewater infrastructure into public health observatories. Mariana explains the concept of wastewater epidemiology, where wastewater samples from communities are collected and analysed for various disease indicators, includin…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Xander Kerman Gregory, the Head of Growth at Ubie Health, to discuss the company's innovative work in early disease prediction through the power of artificial intelligence. Ubie Health focussed on user-centric design to dynamically guide patients through a series of carefully se…
  continue reading
 
In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education. They discuss the importance of patient advocacy, the role of digital health, and the future of patient engagement. Stacey shares her personal journey into patient advocacy and highlights the gaps in knowled…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to veri…
  continue reading
 
Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership. She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI term…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial cal…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…
  continue reading
 
Summary In this episode, Dr. Na-Ri Oh and Ian Wendt discuss Pharmacy Benefit Managers (PBMs) and their impact on drug pricing and patient access to medications. They are joined by Antonio Ciaccia, CEO of 46 Brooklyn Research and president of 3 Access Advisors, which provides insights into the role of PBMs in the drug supply chain. The conversation …
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibl…
  continue reading
 
In this episode, Dr. Na-Ri Oh and Ian Wendt discuss the 340B drug pricing program with guest William Sarraille, a healthcare law expert. They explore the origins of the program and its intended purpose. However, the program has grown exponentially and is now the second largest drug program in the country. Bill raises concerns about the lack of tran…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as …
  continue reading
 
In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in me…
  continue reading
 
Summary Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations. Dr. Shigeta also highlights the importance of timing, luck, and having a clear vis…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Tristan Salomon, Founder and CEO of Axom, a company specialising in advanced AI solutions for the pharmaceutical industry. Tristan Salomon has a rich background in developing and implementing AI technologies to enhance manufacturing processes. His expertise lies in creating innovative solutions that imp…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Johannes Kraus, Co-Founder of YOUTH HealthTech. As a former physical therapist Johannes experienced patients suffering and approaching him every day, barely able to treat their diseases without the ability to properly follow their prevention. He founded YOUTH to prevent diseases by focusing on early det…
  continue reading
 
In this enlightening episode of the RealPharma Podcast, hosts Ian Wendt and Dr. Nari Oh sit down with Dr. Steven King, a luminary in the field of ethnobotanical research and sustainable pharmaceutical development. Dr. King, currently serving as the Chief Sustainable Supply, Ethnobotanical Research, and IP Officer at Jaguar Health, shares his remark…
  continue reading
 
Today Dr Andree Bates chats with Dr Giulio Rognini, Head of Partnerships at Metaphysiks, about how Metaphysiks is revolutionising the world of haptic feedback. Metaphysiks is leading the charge in blending human sensation with the digital realm through their innovative neuro-haptic technology. They’ve even developed the world’s first proprietary ne…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Abishek Jha, Co-Founder and CEO of Elucidata, which cleans and links biomedical data at scale. They advocate for a data-centric approach to AI, arguing that clean data is more valuable than copious data. In this episode, you will learn: How Elucidata’s sources and processes data…
  continue reading
 
Command the Room: Dr. Laura Sicola's Strategies for Executive Communication Excellence Hosts: Dr. Na-Ri Oh and Ian Wendt In this episode of the Real Pharma Podcast, we delve into the intricacies of effective executive communication with Dr. Laura Sicola, a renowned expert in leadership communication and cognitive linguistics. Dr. Sicola has spent o…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eric Doherty, who has worked in the pharmaceutical industry for 33 years and also in healthcare data AI for 4 years. He is the Former President of PERSOWN, Inc., a medical device company that is developing the next generation of instant Point-of-Care (POC) diagnostic testing, us…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research. Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications. In th…
  continue reading
 
Summary Ilisa Bernstein, a senior Vice President at the American Pharmacists Association, discusses the history and current landscape of drug importation policies with a focus on Florida's program. Safety concerns, supply chain issues, and intellectual property rights are key considerations. The impact on the Canadian drug supply and the transparen…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema. Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the ben…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and…
  continue reading
 
Summary In this episode, Kristiaan Rawlings discusses the 2024-2025 Commercial Market Update and Salary Guide produced by EPM Scientific. The life sciences sector remains resilient due to aging populations, scientific advances, and robust investment. Hiring practices and compensation are influenced by these factors across the Americas, Europe, and …
  continue reading
 
Loading …

Quick Reference Guide